Somu Subramaniam is the co-founder and Managing Partner of New Science Ventures. Somu serves on the Board of Directors of Achronix Semiconductor Corporation, Ralexar Therapeutics, Cambridge Epigenetix, Dali Wireless, NorthSea Therapeutics, Oxyrane, Resolve Therapeutics, Svelte Medical Systems and Vascular Therapies. Somu has also served on the Boards of Dezima Pharma (acquired by Amgen), Ception Therapeutics (acquired by Cephalon), BioVex (acquired by Amgen), Lightwire (acquired by Cisco), K2M (acquired by Welsh Carson) and Akarna Therapeutics (acquired by Allergan). Prior to founding NSV, Somu was a director at McKinsey & Company where he advised leading multinational companies in the pharmaceuticals, medical devices, biotechnology, photonics, software and semiconductor industries. At McKinsey, Somu was leader of the Strategy Practice, the Technology Practice, the Biotechnology Group, and the Healthcare Practice. He also served on the firm’s Investment Committee and led its Equity Portfolio Committee. Somu holds a B.Tech. degree from the Indian Institute of Technology and an M.B.A. from Harvard Business School.
William is a Managing Director at Braemar Energy Ventures in NYC where he serves on the Board of Directors for BrightVolt and EnerNOC. Braemar Energy Ventures focuses on investing in early to mid stage energy technology companies primarily in the US and Canada. Prior to joining the Braemar team, William was a partner at Mantis Holdings, a venture capital firm focused on investing in environmental and energy efficiency companies.
William holds both a B.A. in Physics and an M.S. in Energy Sciences from New York University.
Dan is the CEO of Aquam Corp., a global provider of technology solutions for water and energy distribution infrastructure ensuring the health, longevity, safety and reliability of vital resources for utility & municipal, commercial & residential and industrial markets. Aquam’s water and energy technologies diagnose, clean and remediate aging infrastructure & water scarcity issues.
Previously, he has held CEO and executive positions at Scientific Atlanta, St. Bernard Software, Invensys plc, PowerGenix, GT Advanced Technologies, and Verengo Solar. C-level roles have spanned from venture capital backed early-stage companies to billion-dollar global enterprises. Public company leadership roles have included chairmanship of Densei-Lambda, a First Section Tokyo stock exchange company. Mr. Squiller also consults to venture capital and private equity firms where he specializes in technology commercialization, international expansion, turnarounds, and Asian supply chain development.
A graduate of Ohio University with a BS in Electrical Engineering and an MA in Interpersonal Communication, Mr. Squiller also completed the Executive Institute program at Stanford University. He has served on and chaired various Boards of Directors and Advisory Boards for industrial companies, trade organizations, and nonprofits. He currently serves on the boards of Aquam Corp., BrightVolt, and TriLumina Corp.